Wang Ju, Viola Marco, Migliorini Claudia, Paoletti Luca, Arpicco Silvia, Di Meo Chiara, Matricardi Pietro
Department of Drug Chemistry and Technologies, Sapienza University of Rome, 00185 Roma, Italy.
Department of Drug Science and Technology, University of Turin, 10125 Turin, Italy.
Pharmaceutics. 2023 Oct 23;15(10):2508. doi: 10.3390/pharmaceutics15102508.
Nanocarriers have been extensively developed in the biomedical field to enhance the treatment of various diseases. However, to effectively deliver therapeutic agents to desired target tissues and enhance their pharmacological activity, these nanocarriers must overcome biological barriers, such as mucus gel, skin, cornea, and blood-brain barriers. Polysaccharides possess qualities such as excellent biocompatibility, biodegradability, unique biological properties, and good accessibility, making them ideal materials for constructing drug delivery carriers. Nanogels, as a novel drug delivery platform, consist of three-dimensional polymer networks at the nanoscale, offering a promising strategy for encapsulating different pharmaceutical agents, prolonging retention time, and enhancing penetration. These attractive properties offer great potential for the utilization of polysaccharide-based nanogels as drug delivery systems to overcome biological barriers. Hence, this review discusses the properties of various barriers and the associated constraints, followed by summarizing the most recent development of polysaccharide-based nanogels in drug delivery to overcome biological barriers. It is expected to provide inspiration and motivation for better design and development of polysaccharide-based drug delivery systems to enhance bioavailability and efficacy while minimizing side effects.
纳米载体在生物医学领域已得到广泛发展,以加强对各种疾病的治疗。然而,为了有效地将治疗剂递送至所需的靶组织并增强其药理活性,这些纳米载体必须克服生物屏障,如黏液凝胶、皮肤、角膜和血脑屏障。多糖具有优异的生物相容性、生物可降解性、独特的生物学特性和良好的可及性等特质,使其成为构建药物递送载体的理想材料。纳米凝胶作为一种新型药物递送平台,由纳米级的三维聚合物网络组成,为包封不同药剂、延长保留时间和增强渗透性提供了一种有前景的策略。这些吸引人的特性为利用基于多糖的纳米凝胶作为药物递送系统来克服生物屏障提供了巨大潜力。因此,本综述讨论了各种屏障的特性及相关限制,随后总结了基于多糖的纳米凝胶在药物递送中克服生物屏障的最新进展。期望能为更好地设计和开发基于多糖的药物递送系统提供启发和动力,以提高生物利用度和疗效,同时将副作用降至最低。